Additionally, the upregulation of MCP-1 expression in the liver has also been observed in HFD-fed mice exhibiting hepatic steatosis without marked inflammatory lesions [43], suggesting MCP-1 plays crucial roles in the pathogenesis of NAFLD. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.